Orphan Drug PRMA Strategy:
We recommend the optimal price and access strategy with your unique situation in mind
Environmental analysis:
- Competitor environment
- Reimbursement pathways
- Policy surveillance
- Stakeholder engagement
Value communications:
- Global value dossiers
- Value message testing
Price optimization
Launch Sequence
Public affairs strategy
Evidence Mitigation Solutions
We identify potential gaps in your evidence plans and design solutions to mitigate challenges
- Identify gaps in clinical / economic data
- Value messaging
- Strategy workshops
- Publication plan for clinical and health economic data
Bespoke Access Roadmaps
We design customized access roadmaps to give you the most pragmatic and effective route to market
Environment Analysis
- Policy surveillance
- Reimbursement pathways
- Procurement
- Stakeholder group & influencer identification
Competitor tracking
Public affairs strategy
Rare Disease Foresights
We help you learn, and act upon, the latest policy changes, stakeholder and competitor activity
- Disease area burden
- Competitor Landscape
- Health Policy assessment
- Predictive trend analysis
Access Centre of Excellence
We help you get the most from your market access team and individuals
Expert training workshops on:
- What is Market Access?
- Managed entry programs including patient access schemes
- Tender training
- Negotiation strategy
- Business case development
- Strategy workshop